US$ 28.94
bpc 157 less is more BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded Should You Take BPC-157 Peptides?
Description
Sterile multi-dose solution

Weaknesses in Existing Clinical Literature The available clinical literature on BPC-157 is sparse and fraught with methodological weaknesses

The preclinical data is generally consistent and encouraging

That said, peptides arent standalone solutions

They were declining at the six-month mark, but still seemed to be very good and elevated, and thought to still provide good protection against severe disease, hospitalization, and death
